Hyperbaric Chamber and Longevity: Real Benefits, Risks and Limits

Hyperbaric chambers have entered longevity medicine with a mix of good science, bold claims and predictable confusion. The idea is appealing: breathe oxygen under pressure, deliver more oxygen to tissue, trigger repair signals and perhaps influence markers tied to aging. But a serious clinic cannot stop at the attractive headline. The better question is narrower: which benefits are supported in humans, which findings remain early, and when does hyperbaric oxygen belong inside a medical program?

The short answer: hyperbaric oxygen therapy has established medical uses — difficult wounds, radiation injury, carbon monoxide poisoning, decompression sickness — and an emerging research line in aging biology. Human studies have reported changes in telomere length, senescent immune cells, cognitive function and progenitor-cell mobilization. The limits matter just as much: small samples, intensive protocols, few long-term data in healthy adults and no proof that it extends lifespan.

At Progevita, we treat it as a medical tool, not as a rejuvenation shortcut. Its value increases when there is a clear indication, a measured baseline, a defined protocol and follow-up alongside diagnostics, exercise, nutrition, sleep and recovery.

What is a hyperbaric chamber?

A hyperbaric chamber is a medical device that allows a person to breathe oxygen in an environment with pressure above normal atmospheric pressure. Clinical protocols often work between 1.5 and 2.5 ATA — absolute atmospheres — for sessions of 60 to 90 minutes, although the exact pressure, duration and number of sessions depend on the indication and the patient's profile.

Under pressure, oxygen does not only travel bound to hemoglobin. More oxygen also dissolves directly into plasma. That changes tissue delivery, especially in areas where blood flow or oxygen diffusion is compromised. This is why hyperbaric oxygen has been used for wound healing, ischemic tissue, radiation injury and some acute toxic exposures.

The modern field grew from diving medicine, military medicine and decompression sickness. Later it moved into hospitals for selected wounds and radiation complications. The longevity conversation came later, when repeated intermittent exposures were shown to modulate angiogenesis, inflammatory signaling, mitochondrial function and cellular markers linked to aging.

How pressurized oxygen affects cells

The interesting mechanism is not “more oxygen is always better”. That would be poor medicine. The key is intermittent exposure: controlled phases of hyperoxia followed by a return to normal oxygen conditions. This pattern may activate what researchers call the hyperoxic-hypoxic paradox: the body receives abundant oxygen, yet some adaptive pathways respond as if oxygen availability had dropped.

Those pathways include HIF-1α, VEGF, nitric oxide, angiogenesis, progenitor-cell mobilization, inflammatory signaling and mitochondrial adaptation. In plain language: the body can increase vascular repair signals, improve tissue oxygen availability and shift parts of the immune response.

There is also a hormetic component. A controlled stressor can produce an adaptive response. Exercise works in a similar way: a hard session creates physiological stress, but when it is dosed well, the body adapts and becomes more resilient. Hyperbaric oxygen is not exercise, of course. It is a medical intervention that needs patient selection, dosing and supervision.

The Tel Aviv study: telomeres and senescent cells

The study that brought hyperbaric oxygen into the longevity conversation was published in Aging in 2020 by Hachmo, Hadanny, Efrati and colleagues. It included healthy adults aged 64 or older who completed 60 hyperbaric oxygen exposures. The team measured telomere length and senescent immune cells in peripheral blood.

The results drew attention: telomere length increased by more than 20% in several immune-cell populations, with B cells reaching increases close to 38% at some time points. They also reported reductions in senescent T-cell subsets: around -37% in senescent T helper cells and -11% in senescent cytotoxic T cells after the protocol.

This needs careful reading. It does not mean that the whole body “reversed aging”. It means that, in a small human study using a very specific and intensive protocol, researchers observed changes in selected immune markers. That is relevant because it connects with two hallmarks of aging: telomere attrition and cellular senescence. It does not prove that a person will live longer.

A fair interpretation is this: hyperbaric oxygen can influence cellular markers related to aging under specific conditions. That justifies further study and may justify individual clinical use. It does not justify selling guaranteed rejuvenation.

What is established and what remains experimental

The largest gap in online content is that established medical indications are often mixed with longevity promises that remain early. A clearer distinction helps:

Use or claim	Evidence status	How to interpret it
Decompression sickness, carbon monoxide poisoning, complex wounds, radiation injury	Recognized indications in hyperbaric medicine	Clinical use with defined protocols and medical supervision
Telomeres and senescent cells	Small prospective human trial using an intensive 60-session protocol	Interesting biological signal; not proof that a person will live longer
Cognition and cerebral blood flow	Controlled trials in healthy older adults from the Shamir/Tel Aviv group	Promising for function and perfusion; not a universal dementia treatment
Physical capacity, VO2 max and cardiac perfusion	2024 randomized trial in 63 sedentary older adults	Relevant finding, but tied to a demanding protocol: 60 sessions, 2 ATA, 100% oxygen and air breaks
General “anti-aging”, soft chambers or occasional wellness sessions	Common marketing extrapolation	Should not be treated as equivalent to published medical protocols

2026 Update: More Interest, Same Clinical Bar

The current English and Spanish SERPs still split into two camps. Many commercial pages say hyperbaric oxygen “slows aging” by leaning heavily on the 2020 telomere study. Stronger medical resources such as Harvard Health, Cleveland Clinic, the FDA and UHMS separate recognized indications, unapproved claims and safety. A useful patient guide should not simply pick a side. It should distinguish biological signal, medical indication and anti-aging marketing.

Recent literature supports that caution. Fisher et al.'s 2025 systematic review on aesthetics and anti-aging found 15 relevant studies and concluded that HBOT may be a promising adjunct, but evidence remains limited for cost justification, universal protocols or broad claims. At the same time, the FDA's August 2025 safety letter reminds clinicians that HBOT devices are class II medical devices, should be used according to manufacturer instructions and carry increased fire risk in high-oxygen environments. In practical terms: if a center does not discuss indication, screening, pressure, oxygen fraction, air breaks, compatible clothing, prohibited objects and monitoring, the medical layer is missing.

Beyond telomeres: documented benefits

The research line is broader than telomeres. In a randomized controlled trial in healthy older adults, Hadanny and colleagues reported cognitive improvement after hyperbaric oxygen, associated with changes in cerebral blood flow. The hypothesis is that intermittent hyperoxia, angiogenesis and neuroplasticity may improve perfusion in vulnerable brain areas.

In 2024, a randomized trial in BMC Geriatrics added a practical data point: 63 sedentary adults older than 64 were assigned to control or 60 HBOT sessions over 12 weeks. The treated group improved relative VO2 max by an average of 1.91 ml/kg/min, increased oxygen consumption at the first ventilatory threshold and showed higher myocardial blood flow and blood volume on MRI. This matters for physical healthspan, but it does not make a chamber a replacement for training: it points to perfusion and vascular adaptation under a specific medical protocol.

Wound repair is a more established clinical field. Hyperbaric oxygen can support healing in selected cases because it increases tissue oxygenation, stimulates angiogenesis and helps correct local hypoxia. In people with diabetes, radiation injury or vascular compromise, this medical use has more evidence than most anti-aging claims around the therapy.

There is also evidence on stem or progenitor cell mobilization. Thom and colleagues reported that hyperbaric oxygen can mobilize CD34+ cells from bone marrow through nitric-oxide-related mechanisms. That does not mean a chamber regenerates any organ on demand. It means the intervention can activate repair signals that fit with its use in tissue recovery and regenerative medicine.

The possible reduction of senescent immune cells connects with our work on senolytics and zombie cells. The distinction matters: senolytics aim to remove senescent cells through drugs or compounds; hyperbaric oxygen seems to modulate immune-cell populations and repair signaling. These are related fields, not interchangeable treatments.

When it does not work: myths and realism

A hyperbaric chamber does not replace habits. If sleep is poor, training is absent, alcohol is high, insulin resistance is progressing and food quality is weak, pressurized oxygen will not compensate for all of that. It may be useful, but it cannot do the work that belongs to lifestyle, metabolic health and cardiovascular risk control.

Not all protocols are equal either. A low-pressure soft chamber is not the same as a medical protocol with 100% oxygen, supervision and defined parameters. The most cited longevity studies use very specific dosing — for example 2 ATA, 90 minutes, 60 sessions and air breaks — not occasional wellness exposure. Pressure, breathing gas, air breaks and frequency all change the biological stimulus.

Contraindications and precautions matter: untreated pneumothorax, some lung diseases, certain oncology drugs or treatments, acute respiratory infections, middle-ear problems and situations with high barotrauma risk. The most common adverse effects are ear or sinus discomfort. Rarely, oxygen toxicity, seizures, hypoglycemia in people with diabetes treated with insulin or pulmonary complications can occur.

Safety is not paperwork. A systematic review of 24 randomized trials and 1,497 participants found more adverse effects with HBOT than in controls, with ear discomfort as the most frequent event and higher risk when pressure exceeded 2.0 ATA or the course lasted more than 10 sessions. Mayo Clinic and the FDA add a less glamorous but decisive point: oxygen-rich environments increase fire risk, so certified programs need staff training, supervision, compatible clothing, object control and strict safety protocols.

Celebrity marketing deserves caution. A famous person using a chamber does not make the intervention universal. Science is not measured by selfies; it is measured by indications, protocols, outcomes and follow-up. Harvard Health draws a useful patient boundary: there are evidence-based and FDA-cleared uses, while claims for Alzheimer's disease, autism, cancer, Lyme disease or general anti-aging do not have the same scientific backing.

How to choose a center: signs of seriousness

The current English SERP mixes three kinds of pages: clinics listing benefits, media warning against hype and medical guides explaining approved uses. The patient gap is not another list of promises. It is knowing what to ask before entering a chamber.

• Indication: what specific problem is being targeted, and why is HBOT reasonable compared with simpler options?
• Protocol: ATA pressure, oxygen fraction, duration, air breaks, number of sessions and stopping criteria.
• Screening: ears, lungs, diabetes, medication, cancer history, claustrophobia, cardiovascular risk and contraindications.
• Safety: staff training, fire control, allowed objects, monitoring and plan for ear pain, dizziness, anxiety or hypoglycemia.
• Measurement: which biomarker, symptom or functional test will justify continuing, adjusting or stopping.

The Undersea & Hyperbaric Medical Society publishes recognized HBO indications; that framework helps distinguish hyperbaric medicine from pressurized wellness. In longevity, the bar should be even higher: no measurable target, no strong reason to prescribe it.

How it fits inside a longevity program

Hyperbaric oxygen makes more sense inside a program than as an isolated treatment. In longevity medicine, the goal is not “doing sessions”. The goal is improving systems: inflammation, vascular function, recovery, cellular energy, body composition, sleep and physical capacity.

This is where combinations become reasonable. With NAD+ IV, it may fit protocols focused on cellular energy and repair. With plasmapheresis, it can sit inside a wider strategy around circulating inflammatory factors. With an anti-inflammatory diet and exercise, the metabolic environment is less likely to work against the treatment.

It also fits the Balneario de Cofrentes context: volcanic waters and thermal therapy, rest, nature and physiotherapy. Not because the setting is magic, but because recovery, sleep, stress and adherence matter. Advanced interventions tend to perform better when the body is not fighting everything else.

At Progevita, the indication is considered within programs such as Optimization or Inflammaging, after reviewing medical history, biomarkers, goals, contraindications and the rest of the protocol. We measure before deciding and measure again to know whether the intervention was worth it.

Biomarkers to track

If hyperbaric oxygen is used with a longevity goal, it should connect to metrics. Some are general: hsCRP, suPAR when available, glucose, insulin, HbA1c, ApoB, blood pressure, body composition, sleep quality and physical capacity. Others are more specific: cognitive testing, wound healing, pain, fatigue, recovery or immune markers in selected cases. In active adults, this should be cross-checked with the logic of recovery biomarkers for athletes: feeling better after one session is not enough; the question is whether inflammation, sleep, load tolerance or training decisions actually improve.

Epigenetic clocks and telomere length can be interesting, but they should not become laboratory theater. A change in a commercial test is not enough if the person sleeps worse, has more pain or does not improve function. In preventive medicine, the useful data point is the one that changes a decision.

How to know if it may make sense for you

A good indication starts with a simple question: what problem are we trying to solve? Support during tissue recovery, persistent inflammation, fatigue, mild cognitive decline, poor wound healing and general prevention are different goals. Each one requires a different conversation, protocol and outcome measure.

A person who is already fit, asymptomatic and metabolically healthy may get little marginal benefit from a few curious sessions. Someone with low-grade chronic inflammation, poor recovery, metabolic risk, a history of difficult healing or a defined recovery window may be a better candidate, provided there are no contraindications.

Clinical judgment also prevents the opposite mistake: rejecting a therapy just because it has become fashionable. Hype does not invalidate the biology. What matters is separating real indications from weak promises. Hyperbaric oxygen should have a goal, a dose, follow-up and a reason to continue or stop.

Frequently asked questions about hyperbaric chambers

Does a hyperbaric chamber session hurt?

It should not hurt. The most common sensation is ear pressure, similar to flying. The clinical team teaches equalization maneuvers and controls pressurization. If intense pain appears, the session should be adjusted or stopped.

How many sessions are needed?

It depends on the goal. Medical indications use defined protocols. Aging studies have used intensive protocols, such as 60 sessions over 90 days. For longevity, there is no universal number; it should be individualized.

Can hyperbaric oxygen lengthen telomeres?

A 2020 human study reported telomere-length increases in immune cells after 60 sessions. It is a relevant finding, but it does not prove whole-body rejuvenation or guarantee the same response in every person.

Is it safe for older adults?

It can be safe with prior assessment and supervision, but not automatically. In older adults, clinicians should review ear and lung status, cardiovascular risk, medication, cancer history and tolerance to pressure.

How is it different from breathing normal oxygen?

Pressure changes the physiology. Under hyperbaric conditions, more oxygen dissolves in plasma and reaches tissues differently. Breathing oxygen at normal pressure does not reproduce the same stimulus.

Does a soft hyperbaric chamber work for longevity?

It should not be sold as equivalent to published medical protocols. Soft chambers usually operate at lower pressure and often do not reproduce the combination of 2 ATA, 100% oxygen, air breaks and 40-60 sessions used in the most cited studies. They may have wellness uses, but extrapolating effects on telomeres, senescence or VO2 max would be too generous.

How much does it cost?

Price depends on the center, type of chamber, duration, supervision and number of sessions. At Progevita, it is assessed within a personalized protocol rather than sold as a standalone session without medical context.

References

1. Hachmo Y, Hadanny A, Abu Hamed R, et al. “Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial.” Aging. 2020;12(22):22445-22456. DOI: 10.18632/aging.202188. PMID: 33206062.
2. Hadanny A, Abbott S, Suzin G, et al. “Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial.” Aging. 2020;12(13):13740-13761. PMID: 32589613.
3. Hadanny A, Sasson E, Copel L, et al. “Physical enhancement of older adults using hyperbaric oxygen: a randomized controlled trial.” BMC Geriatrics. 2024;24(1):572. DOI: 10.1186/s12877-024-05146-3. PMID: 38961397.
4. Gupta M, Rathored J. “Hyperbaric oxygen therapy: future prospects in regenerative therapy and anti-aging.” Frontiers in Aging. 2024;5:1368982. DOI: 10.3389/fragi.2024.1368982. PMID: 38757145.
5. Thom SR, Bhopale VM, Velazquez OC, et al. “Stem cell mobilization by hyperbaric oxygen.” American Journal of Physiology - Heart and Circulatory Physiology. 2006;290(4):H1378-H1386. PMID: 16299259.
6. Thom SR, Bhopale VM, Fisher D, et al. “Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide.” Stem Cells. 2006;24(10):2309-2318. PMID: 16794267.
7. Fosen KM, Thom SR. “Hyperbaric oxygen, vasculogenic stem cells, and wound healing.” Antioxidants & Redox Signaling. 2014;21(11):1634-1647. PMID: 24730726.
8. Fisher SM et al. “Hyperbaric Oxygen Therapy in Aesthetic Medicine and Anti-Aging: A Systematic Review.” Aesthetic Plast Surg. 2025;49(9):2534-2544. DOI: 10.1007/s00266-024-04553-6. PMID: 39733047.
9. Zhang Y et al. “Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis.” Front Med. 2023;10:1160774. DOI: 10.3389/fmed.2023.1160774.
10. Mayo Clinic. Hyperbaric oxygen therapy: overview, uses and risks.
11. Cleveland Clinic. Hyperbaric Oxygen Therapy: benefits, side effects and unapproved uses.
12. Harvard Health Publishing. Hyperbaric oxygen therapy: evidence-based uses and unproven claims. 2024.
13. U.S. Food and Drug Administration. Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices - Letter to Health Care Providers. 2025.
14. Undersea & Hyperbaric Medical Society. Hyperbaric oxygen therapy indications. 2020.
15. Wang H et al. “Hyperbaric oxygen therapy for osteoporosis: A systematic review of preclinical evidence and mechanisms.” Bone. 2026;205:117772. DOI: 10.1016/j.bone.2025.117772. PMID: 41483655.

This article is for information only and does not replace medical advice. Hyperbaric oxygen therapy should be indicated after reviewing medical history, medication, goals and contraindications.

Want to know whether hyperbaric oxygen makes sense for your case? Request your Progevita hyperbaric protocol assessment.